Optimizing moving average control procedures for small-volume laboratories: can it be done?

被引:18
作者
Lukic, Vera [1 ]
Ignjatovic, Svetlana [2 ,3 ]
机构
[1] Railway Healthcare Inst, Dept Lab Diagnost, Belgrade, Serbia
[2] Univ Belgrade, Fac Pharm, Dept Med Biochem, Belgrade, Serbia
[3] Clin Ctr Serbia, Ctr Med Biochem, Belgrade, Serbia
关键词
quality control; moving average; bias detection simulation; MA Generator software; QUALITY-CONTROL PROCEDURES; CLINICAL-CHEMISTRY; SIGMA-METRICS; OPTIMIZATION; VALIDATION;
D O I
10.11613/BM.2019.030710
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Introduction: Moving average (MA) means calculating the average value from a set of patient results and further using that value for analytical quality control purposes. The aim of this study was to examine whether the selection, optimization and validation of MA procedures can be performed using the already described bias detection simulation method and whether it is possible to select appropriate MA procedures for a laboratory with a small daily testing volume. Materials and methods: The study was done on four analytes: creatinine, potassium, sodium and albumin. All patient results of these tests processed during six months were taken from the laboratory information system. Using the MA Generator software, different MA procedures were analysed. Different inclusion criteria, calculation formulas, batch sizes and weighting factors were tested. Selection of optimal MA procedures was based on their ability to detect simulated biases of different sizes. After optimization, the validation of MA procedures was done. The results were presented by bias detection curves and MA validation charts. Results: Simple MA procedures for albumin and sodium without truncation limits were selected as optimal. Exponentially weighted MA procedures were found optimal for creatinine and potassium, with the upper truncation limits of 150 mu mol/L and 6 mmol/L, respectively. Conclusions: It has been experimentally confirmed that it is possible to perform the selection, optimization and validation of MA procedures using the bias detection simulation method. Also, it is possible to define MA procedures optimal for a laboratory with a small daily testing volume.
引用
收藏
页数:13
相关论文
共 19 条
[1]  
[Anonymous], 1992, FED REG
[2]  
BULL BS, 1974, AM J CLIN PATHOL, V61, P473
[3]   ASSESSMENT OF AVERAGE OF NORMALS QUALITY-CONTROL PROCEDURES AND GUIDELINES FOR IMPLEMENTATION [J].
CEMBROWSKI, GS ;
CHANDLER, EP ;
WESTGARD, JO .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1984, 81 (04) :492-499
[4]   Sigma metrics used to assess analytical quality of clinical chemistry assays: importance of the allowable total error (TEa) target [J].
Hens, Koen ;
Berth, Mario ;
Armbruster, Dave ;
Westgard, Sten .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2014, 52 (07) :973-980
[5]  
HOFFMANN RG, 1965, AM J CLIN PATHOL, V43, P134
[6]   The Reproducibility Wars: Successful, Unsuccessful, Uninterpretable, Exact, Conceptual, Triangulated, Contested Replication [J].
Ioannidis, John P. A. .
CLINICAL CHEMISTRY, 2017, 63 (05) :943-945
[7]   Optimization of a Moving Averages Program Using a Simulated Annealing Algorithm: The Goal is to Monitor the Process Not the Patients [J].
Ng, David ;
Polito, Frank A. ;
Cervinski, Mark A. .
CLINICAL CHEMISTRY, 2016, 62 (10) :1361-1371
[8]  
Ricós C, 1999, SCAND J CLIN LAB INV, V59, P491
[9]   CUSUM-Logistic Regression analysis for the rapid detection of errors in clinical laboratory test results [J].
Sampson, Maureen L. ;
Gounden, Verena ;
van Deventer, Hendrik E. ;
Remaley, Alan T. .
CLINICAL BIOCHEMISTRY, 2016, 49 (03) :201-207
[10]   Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine [J].
Sandberg, Sverre ;
Fraser, Callum G. ;
Horvath, Andrea Rita ;
Jansen, Rob ;
Jones, Graham ;
Oosterhuis, Wytze ;
Petersen, Per Hyltoft ;
Schimmel, Heinz ;
Sikaris, Ken ;
Panteghini, Mauro .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (06) :833-835